background: the main cause of discontinuing the use of depomedroxy progesterone acetate (dmpa) is irregular bleeding. this study compared placebo with two kinds of combined oral contraceptive pills including low dose (ldocp) and high dose (hdocp) on control of abnormal uterine bleeding in dmpa users. methods: ninety dmpa users complaining of bleeding were studied in a triple blind randomized cl...

Family Planning Perspectives In the early 1990s, the U.S. Food and Drug Administration approved subdermal contraceptive implants and the injectable contraceptive depot medroxy progesterone acetate (DMPA), adding two long-term methods to the array of contraceptives currently available. A primary concern associated with these highly effective methods is that, as has been documented among women wh...

Aqueous polyurethane emulsion was prepared with diphenylmethane diisocyanate (MDI), polybutylene adipate diol (PBA-1000) as main raw materials and 2, 2-dihydroxymethyl propionic acid (DMPA) hydrophilic chain extender. On this basis, epoxy resin E-44 introduced to modify the prepolymer, modified waterborne obtained. In order obtain better performance polyurethane, effect of DMPA content、the amou...

The association between contraceptive use and breast-feeding duration was investigated in 2380 women in rural Bangladesh where women usually stop breast-feeding once pregnant. Life table analysis showed that women receiving regular injections of depo medroxy progesterone acetate (DMPA) and those using non-hormonal contraception breast-fed significantly longer than women using no contraception. ...

This paper describes experiments designed to test the effect of depot medroxyprogesterone acetate (DMPA) on calcium metabolism of adult ovariectomized rats. The 24 animals were randomly assigned to control or treated groups. Treated rats received 15 mg of DMPA i.m. per week, during four or twelve weeks. Controls received solvent alone. The variables characterizing the metabolism of Ca (daily ra...

Depo-Provera® is depot medroxyprogesterone acetate (DMPA) aqueous suspension 150 mg in 1 ml formulated for deep IM injection. [2] This is most commonly used. Sayana Press® is DMPA 104 mg in 0.65 ml formulated for SC injection first licensed in the UK in 2011. [3] It is bio-equivalent to Depo-Provera®. It may be preferable to Depo-Provera® in women on anticoagulants or with a bleeding disorder. ...